Synthesis, toxicological, pharmacological assessment, and in vitro bronchodilating activity of some 7-theophyllinylacetyloxyglycols

Archiv der Pharmazie

Volumn 331, Issue 10, 1998, Pages 313-318

  Zlatkov, Alexander ^a   Peikov, Plamen ^a   Danchev, Nikolai ^a   Ivanov, Dimiter ^a   Tsvetkova, Boika ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

7 theophylline acetic acid; Acute toxicity; Aminophylline; Bronchodilating effect in vitro; Glycols; Phosphodiesterase activity

Indexed keywords

7 THEOPHYLLINYLACETYLOXYGLYCOL; ACEFYLLINE; GLYCOL; THEOPHYLLINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BRONCHODILATING ACTIVITY; DERIVATIZATION; DRUG EFFECT; DRUG STABILITY; DRUG SYNTHESIS; ENZYME ACTIVITY; ESTERIFICATION; HUMAN; IN VITRO STUDY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ANALYSIS;

ANIMALS; BEHAVIOR, ANIMAL; BRONCHODILATOR AGENTS; GLYCOLS; GUINEA PIGS; MALE; MICE; RATS; RATS, WISTAR; THEOPHYLLINE;

EID: 0031757944     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4184(199810)331:10<313::AID-ARDP313>3.0.CO;2-I     Document Type: Article

References (23)

1. V. Stefanovich. Drug News Perspect. 1989, 2, 82-88.
2. J. Gagauzov, Pl. Peikov, Al. Zlatkov, Synthesis of compounds of xanthine group. Ed. Centre of scientific information of medicine. Sofia, 1991.
3. Ger. Offen. 2,559.655; Chem. Abstr. 1977, 87, 168096e.
4. K. Credner, B. Geisel, G. Brenner, M. Tausher. Ger. Offen. 2,512,886; Chem. Abstr. 1977, 86, 29885d.
5. K. M. Piafsky, R. I. Ogilvie. New Engl. J. Med. 1975, 292, 1218-1222.
6. C. G. A. Persson, K. E. Anderson, G. Kjelin. Life Sci. 1986, 38, 1057-1072.
7. In: Physicians Desk Reference. Publisher Edward R. Barnhart. Medical Economic Co., Inc., Oradell, N.Y., 1991, pp 1136-1142.
8. C. Hardy, O. Schofield, C.F. Gerge, Brit. Med. J. 1983, 286, 2051-2052.
9. Pl. Peikov, N. Danchev, Al. Zlatkov, D. Ivanov, N. Belcheva. Arch. Pharm. 1995, 238, 615-618.
10. A. Maslankiewicz, B. Rohloff, A. Windisch, Roczniki Chemii 1975, 49, 1935-1938.
11. A. Maslankiewicz, B. Syrek, M. Nocum, K. Pluta, Acta Pol. Pharm. 1979, 36, 539-543.
12. J. Kohen. Analyt. Profiles of Drug Subst. 1975, 4, 468-493.
13. C. Pouchert. The Aldrich Library of NMR Spectra, Ed. II, vol. 2, 1983, pp. 585-587.
14. Pl. Peikov, Al. Zlatkov, N. Belcheva. Compt. Rend. Bulg. Acad. Sci. 1995, 48, 3, 29-32.
15. C. G. A. Person. In: Antiasthma xanthines and adenosines, Copenhagen, 1985, pp. 25-36.
16. U. Windscheif. J. Pharm. Pharmacol. 1996, 48, 993-1011.
17. R. Sakai, K. Konno, Y. Yamamoto, F. Sanae, K. Tagaki, T. Hasegava, N. Iwasaki, M. Kakuichi, H. Kato, K. Miyamoto, J. Med. Chem. 1992, 35, 4039-4044.
18. K. Miyamoto, Y. Yamamoto, M. Kurita, R. Sakai, K. Konno, F. Sanae, T. Ohshima, K. Tagaki, T. Hasegava, N. Iwasaki, M. Kakuichi, H. Kato, J. Med. Chem. 1993, 36, 1380-1386.
19. J. T. Litchfield, F. Wilcoxon, J. Pharmacol. Exp. Ther. 1949, 96, 99-102.
20. J. Castillo, E. De Beer, J. Pharmacol. Exp. Ther. 1947, 90, 104-109.
21. J. Van Rossum, F. Van den Bring, Arch. Int. Pharmacodyn. 1963, 143, 240-246.
22. R. Butcher, E. Sutherland, J. Biol. Chem. 1962, 237, 1244-1250.
23. M. Buell, O. Lowry, N. Roberts, M. Chang, J. Biol. Chem. 1958, 232, 979-84.